For many Americans, the weight-loss medications broadly referred to as GLP-1s are transforming the way they think and feel ...

COPENHAGEN, Feb 24 (Reuters) - Novo Nordisk and United Laboratories International said on Tuesday a Chinese mid-stage trial ...

Bid to improve access to Mounjaro in England, but experts warn eligibility still tightly restricted.

Novo Nordisk said an experimental obesity drug it is jointly developing with China’s United Laboratories International ...

The latest medical science reveals that healthy weight loss doesn't require special genes, diets, or exercise programs. The ...

Almost £150bn has been wiped off Ozempic drugmaker Novo Nordisk after a trial of its new weight-loss drug fell short of ...

Novo Nordisk is suing a Shrewsbury doctor who sells a cheaper compounded medicine version of its popular Ozempic and Wegovy ...

Eli Lilly announced on " Good Morning America " Monday that its GLP-1 weight-loss drug Zepbound will now be available in a ...

Agreement worth up to $495 million is part of a growing number of Chinese deals with global pharma giants as the country ...

The Allurion gastric balloon can be swallowed in a 15-minute office visit and lead to a weight loss of up to 14 percent in 4 ...

The Danish drugmaker’s latest trial setback intensifies its high-stakes rivalry with Eli Lilly in the booming obesity market.

It’s been a topsy-turvy week for Novo Nordisk, makers of the popular weight loss drugs Ozempic and Wegovy. Fresh off the heels of a disappointing trial for one experimental drug, the company has just ...